301201.SZ
诚达药业
SZSE · C 制造业 · CN
CNY 34.43
−3.83%Margins
Gross margin
40.4%
EBITDA margin
18.2%
EBIT margin
0.7%
Net margin
-0.8%
FCF margin
-2.8%
-0.2%
Return on equity
-0.2%
Return on assets
0.2%
Return on invested capital
0.20x
Asset turnover
CNY 45.6M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026